Results 341 to 350 of about 1,006,148 (403)

Plasma lipid levels predict chemotherapy response and survival in acute myeloid leukemia.

Blood
O'Brien C, Nursimulu N, Tyagi A, Culp-Hill R, Arruda A, Murphy T, Minden MD, Kent A, Stevens B, Pollyea DA, Hope K, Kumar S, Reisz JA, D'Alessandro A, Jones CL.   +14 more
europepmc   +1 more source

Fusion gene depletion eliminates stemness and induces bidirectional differentiation of acute myeloid leukemia.

Blood
Derevyanko PK, Swart LE, Mata Casimiro LD, van Oort A, du Plessis M, van den Brink L, Ashtiani M, Zwaan CM, Krippner-Heidenreich A, Bonifer C, Schiffelers R, Vormoor J, Kellaway SG, Heidenreich O.   +13 more
europepmc   +1 more source

Clonal Evolution of Pediatric Acute Myeloid Leukemia and Its Contribution to Disease Relapse

Umeda M, Kolekar P, Huskey AL, Suryaprakash S, Ma J, Li H, Westover T, Walsh MP, Song G, Liu Y, Tran Q, Balagopal V, Wang L, Brady SW, Gruber TA, Pounds S, Mead PE, Karol SE, Inaba H, Rubnitz JE, Ribeiro R, Ma X, Klco JM.   +22 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Chronic myeloid leukemia transformation into acute myeloid leukemia

Indonesian Journal of Biomedicine and Clinical Sciences
Chronic myeloid leukemia (CML) is a myeloproliferative disorder characterized by excessive accumulation of apparently normal myeloid cells and the Philadelphia chromosome resulting from t(9;22) reciprocal chromosomal translocation and leading to BCR-ABL ...
Nugra Akzatama, S. Wardhani
semanticscholar   +2 more sources

Myeloid Leukemia

Methods In Molecular Medicine™, 2020
John M. Walker
semanticscholar   +3 more sources

Chronic myeloid leukemia: 2022 update on diagnosis, therapy, and monitoring

American journal of hematology/oncology, 2022
Chronic Myeloid Leukemia (CML) is a myeloproliferative neoplasm with an incidence of 1–2 cases per 100 000 adults. It accounts for approximately 15% of newly diagnosed cases of leukemia in adults.
E. Jabbour, H. Kantarjian
semanticscholar   +1 more source

Chronic Myeloid Leukemia

Hematology, 2003
AbstractChronic myeloid leukemia (CML) was the first human malignancy to be associated with a specific genetic lesion, the Philadelphia chromosome, harboring the BCR-ABL oncogene. Since then, it has become a paradigm for the discovery of molecular mechanisms and targeted therapeutic approaches in the field of hematologic neoplasias. The past 5 years or
Junia V, Melo, Timothy P, Hughes, Jane F, Apperley   +2 more
openaire   +2 more sources

Acute Myeloid Leukemia

Hematology, 2001
AbstractThrough the hard work of a large number of investigators, the biology of acute myeloid leukemia (AML) is becoming increasingly well understood, and as a consequence, new therapeutic targets have been identified and new model systems have been developed for testing novel therapies.
F R, Appelbaum, J M, Rowe, J, Radich, J E, Dick   +3 more
openaire   +2 more sources

Acute Myeloid Leukemia

Hematology/Oncology Clinics of North America, 2009
The evolution of acute myeloid leukemia (AML) classification reflects greater understanding of the AML pathogenesis. The 2008 World Health Organization classification incorporated cytogenetic and molecular genetic findings and introduced important prognostic correlations.
Amy, Heerema-McKenney, Daniel A, Arber
openaire   +2 more sources